Adoration Home Health Care Mississippi | |
803 East Sunflower Rd, Cleveland, Mississippi 38732 | |
(662) 846-7693 | |
Name | Adoration Home Health Care Mississippi |
---|---|
Location | 803 East Sunflower Rd, Cleveland, Mississippi |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 257305 |
Ownership Type | Proprietary |
Service Area Zip Codes | 38622, 38643, 38646, 38725, 38726, 38730, 38732, 38736, 38737, 38740, 38759, 38762, 38764, 38769, 38771, 38773, 38774, 38781, 38901, 38914, 38917, 38921, 38922, 38923, 38925, 38927, 38928, 38929, 38930, 38935, 38940, 38941, 38943, 38944, 38946, 38947, 38950, 38954, 38957, 38961, 38962, 38963, 38966 |
NPI Number | 1487639548 |
Organization Name | HOME HEALTH CARE SERVICES II, INC. |
Doing Business As | ADORATION HOME HEALTH CARE MISSISSIPPI |
Address | 803 E Sunflower Rd, Cleveland, MS 38732 |
Phone Number | 662-846-7693 |
News Archive
A self-directed walking program shows promise in easing joint stiffness in older women who experienced these symptoms while taking aromatase inhibitor therapy for breast cancer, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.
The Wall Street Journal reports on three ads that focus on health care with roots in the 2008 presidential election, while the Koch brothers have launched health law ads against Democratic senators they deem vulnerable. And many health law critics have accepted the law's subsidies.
A decade ago, America's health care community took on heart attacks with gusto, harnessing the power of research and data to make sure that every patient got the best possible care.
› Verified 1 days ago
Quality Rating: |
News Archive
A self-directed walking program shows promise in easing joint stiffness in older women who experienced these symptoms while taking aromatase inhibitor therapy for breast cancer, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.
The Wall Street Journal reports on three ads that focus on health care with roots in the 2008 presidential election, while the Koch brothers have launched health law ads against Democratic senators they deem vulnerable. And many health law critics have accepted the law's subsidies.
A decade ago, America's health care community took on heart attacks with gusto, harnessing the power of research and data to make sure that every patient got the best possible care.
› Verified 1 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 98.5 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99.1 | 98.6 |
How often the home health team checked patients’ risk of falling | 100 | 99.6 |
How often the home health team checked patients for depression | 99.8 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 72.6 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 65.3 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 99.2 | 96.4 |
News Archive
A self-directed walking program shows promise in easing joint stiffness in older women who experienced these symptoms while taking aromatase inhibitor therapy for breast cancer, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.
The Wall Street Journal reports on three ads that focus on health care with roots in the 2008 presidential election, while the Koch brothers have launched health law ads against Democratic senators they deem vulnerable. And many health law critics have accepted the law's subsidies.
A decade ago, America's health care community took on heart attacks with gusto, harnessing the power of research and data to make sure that every patient got the best possible care.
› Verified 1 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 79 | 79.6 |
How often patients got better at getting in and out of bed | 73.6 | 81.1 |
How often patients got better at bathing | 78.7 | 82.3 |
How often patients’ breathing improved | 63 | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 68.5 | 75 |
How often home health patients had to be admitted to the hospital | 14.8 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 12.7 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 98 | 94 |
News Archive
A self-directed walking program shows promise in easing joint stiffness in older women who experienced these symptoms while taking aromatase inhibitor therapy for breast cancer, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.
The Wall Street Journal reports on three ads that focus on health care with roots in the 2008 presidential election, while the Koch brothers have launched health law ads against Democratic senators they deem vulnerable. And many health law critics have accepted the law's subsidies.
A decade ago, America's health care community took on heart attacks with gusto, harnessing the power of research and data to make sure that every patient got the best possible care.
› Verified 1 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
A self-directed walking program shows promise in easing joint stiffness in older women who experienced these symptoms while taking aromatase inhibitor therapy for breast cancer, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.
The Wall Street Journal reports on three ads that focus on health care with roots in the 2008 presidential election, while the Koch brothers have launched health law ads against Democratic senators they deem vulnerable. And many health law critics have accepted the law's subsidies.
A decade ago, America's health care community took on heart attacks with gusto, harnessing the power of research and data to make sure that every patient got the best possible care.
› Verified 1 days ago
The patient survey data of Adoration Home Health Care Mississippi is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 93 | 88 |
Percent of patients who reported that their home health team communicated well with them | 89 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 85 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 92 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 91 | 78 |
News Archive
A self-directed walking program shows promise in easing joint stiffness in older women who experienced these symptoms while taking aromatase inhibitor therapy for breast cancer, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.
The Wall Street Journal reports on three ads that focus on health care with roots in the 2008 presidential election, while the Koch brothers have launched health law ads against Democratic senators they deem vulnerable. And many health law critics have accepted the law's subsidies.
A decade ago, America's health care community took on heart attacks with gusto, harnessing the power of research and data to make sure that every patient got the best possible care.
› Verified 1 days ago
Sunflower Home Health Location: 210 North Street, Cleveland, Mississippi 38732 Ratings: Phone: (662) 756-4676 | |
Adoration Home Health Care Mississippi Location: 803 East Sunflower Rd, Cleveland, Mississippi 38732 Ratings: Phone: (662) 846-7693 |